G. Hardavella (Athens, Greece), A. Kempa (Hemer, Germany), N. Triller (Golnik, Slovenia), K. Zarogoulidis (Thessaloniki, Greece)
Usefulness of serum procalcitonin in lung cancer patients with elevated serum C-reactive protein level
H. J. Ban, S. G. Ji, S. Y. Chi, E. Y. Kim, Y. H. Kim, K. S. Kim, I. J. Oh, Y. C. Kim, Y. S. Kwon, Y. I. Kim, S. C. Lim (Dongku, Republic Of Korea)
|  |
Procalitonin: A prognosis factor in lung cancer and a marker for small-cell lung cancer
M. Patout, V. Brunel, M. Salaun, S. Bota, L. Thiberville (Rouen, France)
| |
Serum levels of interleukin 8 and plasma levels of osteopontin in patients with non-small cell lung cancer during chemotherapy
E. Rogala, A. Rozy, B. Roszkowska-Sliz, J. Chorostowska-Wynimko, K. Roszkowska-Sliz (Warsaw, Poland)
| |
Role of C reactive protein in non small cell lung cancer staging
J. A. Torrecilla, S. Scrimini, J. Sauleda, F. de Borja García-Cosío, A. Noguera, A. Iglesias, A. Ríos, R. Córdova, A. Agustí (Palma Mallorca, Bunyola, Barcelona, Madrid, Spain)
|  |
The prognostic value of anemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer
M. Sandelin, G. Holgersson, C. Janson, S. Ekman, M. Bergqvist (Uppsala, Sweden)
| |
Analysis of the clinical feature of 383 patients with lung cancer
Y. Zhou, Y. Li, W. Huang, X. Cai, Q. Zeng, L. Huang (Guangzhou, China)
| |
TTF-1 in advanced SCLC – Diagnostic and prognostic relevance
D. Misch, J. Kollmeier, S. Griff, C. Boch, K. Zimmermann, T. Blum, W. Grüning, T. Mairinger, T. Bauer (Berlin, Germany)
| |
Pulmonary primary adenocarcinoma: Diagnosis, treatment and outcome
F. Chermiti Ben Abdallah, D. Achour, S. Boudaya, A. Chtourou, S. Taktak, R. Mahouachi, A. Ben Kheder (Ariana, Tunisia)
| |
Early complications after lung resections at patients treated for lung cancer with and without neoadjuvant hemiotheraphy
G. Kondov, Z. Spirovski, T. Trajkovska, S. Jovev, I. Topuzovska Kondova, N. Tolevska, B. Kondov (Skopje, Fyrom)
| |
Patterns of recurrence after resection surgery of lung cancer: Clinical correlations and survival
M. G. Cortez Montero, R. Dacal Quintas, J. Abal Arca, M. J. García García, M. T. Alves Perez, P. Marcos Velazquez (Orense, Spain)
| |
Radiofrequency ablation in the treatment of malignant lung tumors
A. Reshetov, I. Rutkin, S. Lazarev, E. Topuzov, V. Balashov (Saint-Petersburg, Russian Federation)
| |
Second primary lung cancers developed following different system tumors
C. Ozdilekcan, S. Turanli, N. Songur, H. Cakmak (Ankara, Turkey)
| |
Cellular atypia and lung cancer
C. António, F. Luís, S. Correia, N. Sousa, L. Ferreira (Guarda, Portugal)
| |
Albumin-bound paclitaxel (nab-P) may play an important role in the treatment of non-small-cell lung cancer (NSCLC) patients
A. Kavvadias, A. Charpidou, I. Gkiozos, G. Tsoukalas, K. Syrigos (Athens, Greece)
| |
Smoking habits and erlotinib response in non-small-cell lung cancer (NSCLC) treatment
R. Monteiro, A. Antunes, I. Gonçalves, C. Lima, A. Barroso, S. Neves, S. Conde, B. Parente (Vila Nova de Gaia, Portugal)
| |
What outcome after the prescription of neoadjuvant chemotherapy in lung cancer?
H. Smadhi, M. S. Boudaya, A. Marghli, F. Charmiti, S. Ouerghi, J. Mohamed, E. Brahem, B. Smati, T. Mestiri, T. Kilani (Ariana, Tunisia)
| |
Effect of cardiovascular comorbidities on the survival patients with stage I and II non-small-cell lung cancer
D. Bursac, N. Secen, D. Sazdanic-Velikic, G. Stojanovic, A. Tepavac, Z. Lozanov-Crvenkovic (Sremska Kamenica, Novi Sad, Republic Of Serbia)
| |
Metastatic bronchopulmonary carcinoid
F. Triest, K. Nackaerts, C. Dooms (Leuven, Belgium)
| |
Primary posterior mediastinum epithelioid angiosarcoma complicated with pulmonary thromboembolism: A case report
Y. Su, B. Gao, J. Liu, H. Xie (Shanghai, China)
| |
A 55 year old man with bilateral pulmonary nodules, neuropathy and renal nodules
V. Pathak, G. Aryal, L. Clouse (Marshfield, United States Of America)
| |